Literature DB >> 18507609

Implanon: a new contraceptive implant.

Mary A Fischer1.   

Abstract

Women who cannot use hormonal contraception containing estrogen have a variety of progestin-only contraceptive methods from which to choose. Implanon is a new single-rod progestin-only contraceptive implant that is easily inserted and can remain in place for up to 3 years. It is highly effective with a rapid onset of action and an equally rapid return of fertility once removed. Counseling is important to help women decide if this method is appropriate for their needs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507609     DOI: 10.1111/j.1552-6909.2008.00247.x

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  7 in total

1.  Determinants of Implanon Discontinuation among Women Who Use Implanon at Bahir Dar Town Health Institutions, Northwest Ethiopia, 2019: A Case-Control Study.

Authors:  Tsegaw Yehuala; Ergoye Melese; Kassawmar Angaw Bogale; Baye Dagnew
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-24       Impact factor: 2.629

2.  Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement.

Authors:  Ai Lin Chin; Shan Jiang; Eungyo Jang; Liqian Niu; Liwu Li; Xiaoting Jia; Rong Tong
Journal:  Nat Commun       Date:  2021-08-26       Impact factor: 17.694

3.  Transgender Women's Concerns and Preferences on Potential Future Long-Acting Biomedical HIV Prevention Strategies: The Case of Injections and Implanted Medication Delivery Devices (IMDDs).

Authors:  Christine Tagliaferri Rael; Michelle Martinez; Rebecca Giguere; Walter Bockting; Caitlin MacCrate; Will Mellman; Pablo Valente; George J Greene; Susan G Sherman; Katherine H A Footer; Richard T D'Aquila; Alex Carballo-Diéguez; Thomas J Hope
Journal:  AIDS Behav       Date:  2020-05

Review 4.  Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.

Authors:  Andrew Owen; Steve Rannard
Journal:  Adv Drug Deliv Rev       Date:  2016-02-23       Impact factor: 15.470

Review 5.  The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients.

Authors:  Magdalena Janczura; Szymon Sip; Judyta Cielecka-Piontek
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

6.  Infection-mimicking materials to program dendritic cells in situ.

Authors:  Omar A Ali; Nathaniel Huebsch; Lan Cao; Glenn Dranoff; David J Mooney
Journal:  Nat Mater       Date:  2009-01-11       Impact factor: 43.841

Review 7.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.